vimarsana.com

Page 24 - நாஸ்டாக் முதல் வடக்கு ப்ரிமியர் வளர்ச்சி சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AlzeCure announces positive data from clinical study with ACD440

AlzeCure announces positive data from clinical study with ACD440 AlzeCure announces positive data from clinical study with ACD440 AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, today announced that the company has received positive results from the phase Ib clinical study with its drug candidate ACD440 for neuropathic pain. The results, presented slightly ahead of plan, demonstrate that ACD440, a TRPV1 antagonist and AlzeCure’s drug candidate for neuropathic pain within the company s Painless platform, was able to demonstrate positive proof-of-mechanism data, showing analgesic efficacy in man. The observed effects with ACD440 were highly significant over placebo. Also, it was well tolerated as a topical gel on human skin which indicates good suitability for further clinical devel

Auriant Mining AB (publ ) Annual Report for 2020

Auriant Mining AB (publ.) Annual Report for 2020 http://www.auriant.com/eng/reports-and-releases/2020 The printed version of the Annual Report can be ordered by mail, Auriant Mining AB, Box 55696 102 15 Stockholm; telephone +46 707 277 097 or by e-mail: ir@auriant.com Danilo Lange, CEO E-mail: Short name: AUR www.facebook.com/AuriantMining/ Auriant Mining AB (AUR) is a Swedish junior mining company focused on gold exploration and production in Russia, primarily in Zabaikalye and the Republics of Khakassia and Tyva. The company has currently four assets, including two operating mines (Tardan and Solococon), one early stage exploration asset and one development asset. Since July 19, 2010, Auriant Mining s shares are traded on Nasdaq First North Premier Growth Market under the short name AUR. For more information please visit www.auriant.com. Mangold Fondkommission is Certified Adviser to Auriant, for more information please call +46 8 503 015 50, e-mail

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.